Background There is an increased interest in the monetary value of a quality-adjusted life-year (QALY). Past studies commonly derived willingness to pay (WTP) for certain future QALY gains. However, obtaining valid WTP per QALY estimates proved to be difficult. Objective We conducted a contingent valuation study and estimated the individual WTP per QALY under risk. We demonstrate the impact of probability weighting on WTP per QALY estimates in the Netherlands. Results Our estimates of the value of a QALY are in the range of €80,000-110,000 when the weighting correction was applied, and €250,500 without correction. The validity of these estimates, applying probability weighting, appears to be good. Conclusions Given the reasonable support for their validity and practical meaningfulness, the estimates derived while correcting for probability weighting may provide valuable input for the debate on the consumption value of health. While decision makers should not apply these estimates without further consideration, since strictly individual valuations may not carry all relevant information and values for societal decision-making, the current estimates may provide a good and informed basis for further discussion and study of this important topic.
Introduction
Policy-makers in the healthcare sector increasingly use information from economic evaluations to optimize the allocation of scarce healthcare resources. These evaluations, which commonly compare two or more alternative interventions in terms of costs and health outcomes, often take the form of a cost-utility analysis (CUA), using qualityadjusted life-years (QALYs) as the outcome measure.
Comparing two interventions yielding costs and health gains only in the current year t, the common welfare economic decision rule would require the value of the benefits of moving from one to the other intervention to exceed the costs (e.g. Gravelle et al. [1] ):
where v t denotes the consumption value per unit of health (QALY) at time t, Dh t indicates the change in the number of QALYs at time t, and Dc t denotes the change in (consumption) costs at time t. The term v t Dh t thus denotes the monetary benefits of the QALYs gained at time t. Equation (1) can be rewritten as:
indicating that the costs to produce one additional QALY should not exceed the value of a QALY ('threshold value') if an intervention is to be considered welfare improving. Note that the threshold and decision context can be viewed in several ways (e.g. Claxton et al. [2] ). A common interpretation, also used here, is that it reflects the consumption value that a society places on marginal health gains, i.e. the monetary value society is willing to pay (or the consumption it is willing to forego) to obtain an additional unit of health (i.e. a QALY). Under that definition, the appropriate level of the threshold is essentially an empirical question regarding the consumption value people place on health gains, which is addressed in this study.
Given the importance of choosing a particular CUA threshold for healthcare decision-making, thorough empirical inquiries into the willingness to pay (WTP) for a QALY remain pivotal. However, eliciting a unique estimate of the WTP per QALY is theoretically and practically problematic [3] [4] [5] [6] [7] [8] . This may partly explain why published empirical estimates [9] [10] [11] [12] [13] [14] have not been adopted in any direct sense by policy-makers. Still, notwithstanding the apparent difficulties of deriving appropriate valuations of QALY gains, empirical investigations of the value of a QALY can yield important insights for the debate about the value of health [15] . However, it is crucial to ensure the theoretical validity and practical usefulness of such empirical valuations, which has been insufficiently demonstrated in empirical studies so far [8] .
Here, we report on an empirical study of the monetary value of a QALY in the Netherlands, using contingent valuation (CV) to obtain individual WTP estimates under risk. This study adds to the literature in several ways. First, to our knowledge, WTP per QALY estimates have not been elicited in the context of uncertainty. Valuations under uncertainty may be seen as better reflecting real-life decision-making, especially when health is concerned. We also analyse the scale sensitivity of WTP per QALY estimates obtained under risk. Such validity tests are crucial if estimates are to inform public debates or policy making. Thorough validity checks are rare, but commonly indicate a poor validity of WTP estimates [5, 8] . Second, our study explores the effect of the non-linear treatment of probabilities (probability weighting) on WTP per QALY estimates and their scale sensitivity. Probability weighting is a common violation of expected utility theory and an important aspect of prospect theory [16, 17] , the currently dominant theory of decision-making under risk. Still, the effect of probability weighting on WTP per QALY estimates and their validity has remained underexplored [18] . Third, we compare our findings (and their validity) with those obtained in a highly comparable study that estimated the individual WTP per QALY but under certainty [8, 11] . This allows the investigation of the effects of introducing risk in eliciting WTP per QALY exercises, both on the size of estimates and on their validity.
In this study we therefore (i) estimated the individual WTP per QALY under risk and investigated the influence of probability weighting on WTP per QALY estimates and their validity and (ii) compared these estimates and their validity with individual WTP per QALY estimates under certainty elicited in a highly comparable study [8, 11] .The paper is structured as follows. Section 2 describes the methods; Sect. 3 presents the results, while in Sect. 4 we discuss our findings and their implications.
Methods
In order to study the WTP for QALY gains in the Dutch population, we administered an online questionnaire (examples of questions given in Appendix [see the electronic supplementary material for all appendices]). Respondents did not receive any financial incentive to participate in the questionnaire; however, upon completion, a small sum was donated to a charity of the participant's choice. We describe the design of the questionnaire and the data analysis in this section.
The Questionnaire
An Internet sampling company recruited a representative sample of the Dutch population. The respondents were first informed about the purpose and content of the research and then offered two 'warm-up' WTP questions for non-healthrelated items (a car and a pair of shoes). They were asked to describe their current health using the EuroQoL-5D (EQ-5D) descriptive system and a visual analogue scale (VAS) ranging from worst imaginable (score 0) to best imaginable health (score 100). The introduction included a graphical explanation of the concept of risk and probability to improve respondents' understanding of the exercise [19] , similar to that used in the recent EuroVaQ project (example included in Appendix 2). Respondents were subsequently randomly assigned to a scenario consisting of two EQ-5D health states and asked to indicate which of the two health states they considered better. Next, they were asked to rate both health states on a VAS and to imagine being in the better health state. We then asked about respondents' WTP for reducing the risk of spending 1 year in the worst health state, starting the next day. The expected gain thus consisted of the difference in utility value between the two health states (i.e. a difference in quality of life [QOL] ), combined with the stated duration of the health decrement (1 year throughout) and the risk of the health decrement occurring. Two WTP questions followed (hereafter labelled as Q1 and Q2, example in Appendix 3), varying only in terms of the size of the risk reduction. Respondents were instructed that the risk of the QOL decrement could be reduced by taking a painless medicine once a month over 1 year. The medicine would have to be paid for out of pocket in 12 monthly instalments. The respondents were reminded that a risk of for instance 10 % meant having a 10 in 100 chance of the health decrement occurring and a 90 in 100 chance of no health decrement.
A two-step procedure was applied in eliciting WTP [11] . First, respondents were presented with an ordered low-tohigh payment scale (PS) of monthly instalments between €0 and €2,500 and asked to indicate the maximum amount they certainly would pay, and the minimum amount they certainly would not pay, to reduce the probability of illness, providing a range of uncertainty values [20, 21] (an example is given in Appendix 4). Second, respondents were presented with a bounded direct 'open-ended' (OE) follow-up question and asked to indicate the maximum amount they would indeed pay if asked to do so right now. The boundaries of the OE question were determined by their response to the PS question. The answer to the OE question was taken as the appropriate estimate of the individual maximum WTP for a QALY and thus used for the calculation of the average WTP per QALY.
To increase the chance of obtaining reliable estimates, the respondents were reminded to take their household income into consideration when solving the exercise. The visual image of the health states rated on the VAS remained in view on the right-hand side of the screen during the WTP exercise. Ex post, respondents were asked how confident they were about their WTP (either [1] totally sure; [2] pretty sure; [3] maybe yes, maybe no; [4] probably not; [5] surely not). Respondents who chose €0 as their maximum WTP were asked why. Answer options were (1) I am unable to pay more than €0; (2) avoiding the worst health state and remaining in the better health state is not worth more than €0 to me; (3) I am not willing to pay out of ethical considerations; and (4) other (open text field for explanation). Options (1) and (2) were considered as the 'true' WTP, options (3) and (4) were defined as a protest answer. Finally, we asked for respondents' socioeconomic and demographic data.
The questionnaire was pilot-tested on a random sample of 100 respondents to determine feasibility and to test the range of the PS.
Scenario Design
Respondents were randomly assigned to one of 29 scenarios consisting of two EQ-5D health states (Appendix 1). The 29 scenarios were based on 42 health states (i.e. some health states were used in more than one scenario), combined to represent a fair spread on the utility plane. The health states were previously used for deriving the British [22] and Dutch [23] EQ-5D tariffs and used in a similar setting by Gyrd-Hansen [10] . Some health states and scenarios were designed explicitly to test the sensitivity to scale (i.e. several scenarios with the same probability level shared one of the two health states). Most scenarios were designed such that one health state was clearly dominant (the difference [0.2 QALY).
Each scenario was accompanied by two questions (Q1 and Q2). In Q1, respondents were asked to indicate their WTP to reduce the probability of the QOL decrement to zero (e.g. from a 50 % chance to a 0 % chance). In Q2, respondents were asked to indicate their WTP to reduce the probability of the QOL decrement by a half (e.g. from a 50 % chance to a 25 % chance). Four probability combinations were used (Table 1) . To ensure the valuation of sufficiently small (marginal) expected gains, smaller probabilities were generally combined with larger potential health decrements, and vice versa (Appendix 1). The (nonweighted) expected QALY gain ranged from 0.002 to 0.066, according to the Dutch tariff. Given the lowest and highest values of the PS, the implied WTP ranged between €1,818 and €15,000,000 per QALY. The wording between Q1 and Q2 did not vary nor emphasize the difference in the probability reduction. 
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Computation of Expected Quality-Adjusted LifeYear (QALY) Gains
The utility value of the difference between the two health states was determined using the Dutch EQ-5D tariffs [23] as well as the sample-specific VAS scores, calculated as:
where X raw denotes the individual's VAS score for each the health states, and X mean of death and X mean of perfect health denote the mean sample VAS scores for the states 'death' and 'perfect health', respectively. The rescaling procedure accounts for the EQ-VAS endpoints being labelled as 'best imaginable health' and 'worst imaginable health' rather than 'death' and 'perfect health', to allow for health states worse than death [24, 25] . Assuming zero discounting, the expected QALY gain (EQ) was calculated as:
where U(HS 1 ) -U(HS 2 ) is the QOL decrement based either on Dutch EQ-5D tariffs or on the rescaled VAS scores and p is the reduction in risk of moving from the better to the worse health state. p was applied directly (as presented in the questionnaire) and as weighted probabilities (the next section offers more details on the weighting procedure). The average WTP per QALY was calculated as:
where hOE(WTP)/EQi is the average of the ratios between the OE WTP and the EQ for every data row, multiplied by 12 monthly instalments. For comparison, this ratio was also calculated using the maximum amount that people were sure they would pay as indicated on the PS. The variation in responses was examined according to (i) the level of certainty regarding WTP answers, (ii) the level of household income, and (iii) individual health status.
Probability Weighting
The expected QALY gains were computed using nonweighted probabilities (i.e. those presented in the questionnaire) and weighted probabilities. Probabilities were weighted to correct for the violations of the axioms of expected utility [26, 27] that occur because respondents tend to treat probabilities non-linearly [16, 17, [26] [27] [28] , as described by the currently dominant theory of decisionmaking under risk, i.e. the cumulative prospect theory [16, 17] . In prospect theory, the probability weighting functions allow for probabilities to be weighted non-linearly. It has been suggested that subjective probability function is S-shaped, overweighting low-probability and underweighting high-probability outcomes. It is concave at lowerprobability outcomes and convex at higher-probability outcomes. The estimated point of inflection varies between 0.3 and 0.4 [17, 31, 29] . Such violations of expected utility theory are especially prevalent in studies offering lowprobability, high-consequence events [30] , as partly the case here, and might lead to biased WTP estimates if ignored. Previous studies have shown the importance of non-linear probability weighting in explaining choices regarding health, life, and death [30] and in explaining a variety of field data [26] . Three specifications of the probability weighting function were used to investigate the impact of the nonlinear probability weighting on WTP per QALY estimates (Table 1) : the one-parameter Tversky and Kahneman (TK) [17] function, the two-parameter Gonzalez and Wu (GW) [31] function, and the one-parameter Prelec (P) [29] function. The TK and P functions were estimated using function parameters estimated by Bleichrodt and Pinto Prades [32] in the medical decisionmaking domain. The GW function was estimated using the Abdellaoui [33] parameters for losses, obtained in the context of monetary decision-making Because the probabilities used in this study are mostly small, the weighting procedures predominately increased the size of probabilities (Table 1) .
Validity
The validity of WTP per QALY estimates was tested by examining the sensitivity of the 'raw' WTP estimates (i.e. those obtained from the OE question) to the change in the size of the expected QALY gain on offer. The variation in the size of the expected QALY gains could stem either from the changes in the size of QOL decrement, or from the changes in the size of the risk reduction.
First, we examined whether respondents provided a significantly higher WTP when faced with larger risk reductions (compared with smaller risk reductions), holding the QOL decrement constant (within scenarios, e.g. 4 % in Q1 and 2 % in Q2). Second, we examined whether respondents provided significantly higher WTP in scenarios offering larger QOL decrements, holding the size of the risk reduction constant (e.g. between scenarios 4 and 5; Appendix 1). Larger expected gains were expected to receive statistically higher WTP values, and the relationship between the size of the gain and WTP was anticipated to be non-proportional, likely concave shaped as commonly assumed [34] [35] [36] .
The degree of non-proportionality is also relevant. In principle, finding a significant difference between two gains (in the expected direction), or establishing the 'theoretical validity' of the results, demonstrated by a significant (and positive) coefficient of the health gain in a regression explaining the variance in WTP [37] , is an important but not a sufficient condition for establishing the usefulness, or practical meaningfulness, of the results. For instance, a WTP of €55 for 1 QALY may be significantly higher than a WTP of €50 for 0.1 QALY, and thus support sensitivity to scale, but may cast doubt on the usefulness of the responses. The observed increase in WTP should also be 'practically meaningful' [8] or 'theoretically plausible' [36] to be considered useful. This can be established by evaluating the degree of non-proportionality between WTP and QALY gains [38, 39] . For small risk reductions and marginal gains, near-proportionality has been proposed as benchmark [40] , which would lead to a (near) constant WTP per QALY across different-sized gains. Although somewhat restrictive and arbitrary, we use this condition of near-proportionality here as a benchmark.
Statistical differences were tested using the parametric t test on log-transformed WTP estimates and the nonparametric Mann-Whitney U test. The distributional properties of WTP estimates were analysed using Kurtosis and Shapiro-Wilk tests. The theoretical validity of WTP estimates was tested using log-linear regressions. The covariates were tested for non-linearity (using quadratic terms) and relevant interactions (excluded if insignificant). Analyses were performed in STATA11.
Results
Our sample consisted of 1,004 respondents, representative of the Dutch population in terms of age (18-65 years), gender and education ( Table 2 ). The monthly average net household income of €2,630 per 2.49 household members was almost equal to the Dutch national figures for 2009 [41] . The pilot did not reveal particular problems concerning the design of the questionnaire. A low dropout rate, reasonable completion time, and plausible answer pattern implied that respondents had no obvious difficulties with understanding or solving the tasks at hand. Respondents had the opportunity to comment on the questionnaire and tasks at the end of the pilot but gave no indication that they were unrealistic.
Patterns in Willingness-to-Pay (WTP) Data
Most WTP values (79 %) were fairly well-dispersed within the range of €0-300. Of respondents, 1.3 % indicated the highest level offered on the PS as their maximum WTP (€2,500) and 87 respondents indicated in one or more scenarios a WTP of €0 (while only 24 indicated €0 in both Q1 and Q2). The reasons for zero WTP were uniformly distributed among the explanations. No consistent relationship was found between the size of the health gain, household income and zero WTP. Given the low number of zeros, especially those that can be interpreted as protest zeros, we decided to retain them in further analyses.
In 96 % of the scenarios, the dominant health state was ranked higher; 42.8 % of the respondents indicated they were either 'pretty' or 'totally' sure that they would pay the stated amount for the specified health gain, while 15.8 % indicated that they would probably or surely not do so. Seven data points were missing for Q2.
WTP per QALY
WTP per QALY obtained using the EQ-VAS scores were comparable to the results obtained using the EQ-5D tariffs, diverging about 10 % in size and supporting the same conclusions regarding the theoretical validity and scale sensitivity. Hence, only the results using EQ-5D tariffs are reported.
The average estimates of WTP per QALY (OE) were calculated using the responses to both Q1 and Q2 ( Table 3 ). The maximum average WTP per QALY, without the correction for probability weighting, was €250,500. After correction, WTP per QALY ranged between €80,800 and €113,000. The estimates obtained using the TK and the GW functions were almost identical (around €110,000), in spite of different function specifications and origins of parameter estimates. Because of the close similarity, and because we estimated the TK function using health domain-specific parameters (rendering them more suitable in this context), we do not present the GW estimates in the rest of the analysis.
The P function yielded the largest expected QALY gain in the denominator (0.036) and, therefore, resulted in the most conservative estimates of WTP per QALY (OE €80,800). The WTP per QALY estimates based on the lower bound PS responses were about 45 % lower than those based on the OE results. Given the skewedness of the data, median values of WTP per QALY were lower than the means, although of similar relative sizes.
WTP per QALY (OE) values varied, as expected, with the levels of respondents' certainty regarding responses and household income. Income showed a clear pattern in both means and medians, with higher valuations for higher income groups (p \ 0.05). Respondents expressing higher levels of certainty generally indicated lower WTP per QALY estimates. This pattern has been observed before [42] , but not in all settings [11] . The group indicating 'maybe yes, maybe no' disturbed this pattern somewhat (p \ 0.05), possibly signalling a more fundamental uncertainty. The medians also show a more mixed pattern. Table 4 presents the results of sensitivity tests, keeping QOL changes constant and varying the size of risk reduction. The average monthly WTP response in Q1, offering a larger gain, was statistically significantly larger than that in Q2 (€185 [ €132, mean ratio 0.71; p = 0.00).
Validity
Without correcting for probability weighting, the ratio of the expected health gains in Q1 and Q2 was 0.5, as implied by the design. Hence, a reduction of 50 % in the size of the non-weighted expected gain between Q1 and Q2 resulted in a reduction in WTP of 29 %, which can be considered concave (and thus theoretically valid), but not near-proportional (and thus practically meaningful), according to our definition.
When correcting for probability weighting, however, the ratios of the weighted expected health gains increased (i.e. 0.67 and 0.8 for the TK and P function, respectively). In other words, when using the TK function, a 33 % reduction in expected health gain resulted in a 29 % reduction in WTP. This is concave and may be considered near-proportional and thus practically useful. When using the P function, a 20 % reduction in expected health gain was accompanied by a 29 % reduction in WTP. This is less proportional than under the TK correction and represents an uncommon convex relationship. This emphasizes the importance of choosing an appropriate weighting function. Median values showed similar ratios. Table 4 also shows the mean WTP per QALY estimates obtained in Q1 and Q2 separately. WTP per QALY estimates were almost constant between Q1 and Q2 when probabilities were weighted (p = 0.23), but considerably different (p = 0.00) without the correction. This is another indication of insensitivity when not correcting for probability weighting, since, from a theoretical and practical perspective, the average point WTP per QALY estimate should not depend on the variation of the expected gain. In other words, the respondents should adjust their WTP to the gain on offer, leading to a more or less constant WTP per QALY across different sized gains. Importantly, this may hold only for marginal gains such as the ones offered here (this issue is further addressed below).
WTP results were also compared within four distinct scenarios offering different QOL decrements but using identical risk reductions. Most of the higher expected gains received higher and statistically different WTP estimates, although WTP and the expected gains were not as proportional as when the size of the risk reduction varied. This finding can perhaps be attributed to a small sample size solving each scenario (35 respondents vs. 1,000 respondents in the previous test) and, hence, the influence of lone outlying values on the results. Thus, although the comparisons between scenario results yielded favourable results, their interpretation should be approached with caution.
Log-linear regressions, with log-WTP as the dependent variable (Table 5) , confirm the theoretical validity of the WTP estimates. Independent variables included the size of the QALY gain on offer (non-weighted, TK; p \ 0.05), log-income (p \ 0.05) and the most relevant socio-demographics, which all carry the expected sign. The results of the P and GW function were similar to those of the TK function and thus not shown.
Although Income is an important determinant of WTP, testing whether it is also a constraining factor is relevant for confirming the 'goodness' of the results. If the expected gains are marginal, they should not affect the marginal utility of income and restrict the size and the variation in WTP estimates. The hypothesis of such income effect [35, 43] was tested by examining the ratios between the WTP for larger gains in Q1 and the smaller gains in Q2, both for respondents with an income below the mean and median and for those above. If budget constraints played a role, this ratio should be larger for higher-income respondents, since their ability to express a 'true' WTP was less constrained [5] . In our study, this ratio was 1.52 for low-income and 1.29 for high-income respondents, indicating in fact a larger variation in WTP among low incomes and thus considerably reducing the concern about the budget constraint.
The Comparison with WTP per QALY Obtained
Under Certainty
The design of the current study was identical to that of Bobinac et al. [11] , except in two aspects: (i) the introduction of risk; and (ii) reduction of the number of WTP questions from five to two, decreasing the (potential) cognitive burden of the exercise. Both studies used large, representative samples of the Dutch population. Nonetheless, results differed considerably between studies, in terms of both point estimates and sensitivity. The average WTP per QALY obtained under certainty was €24,500 [11] , lower than the estimates found in the current study. The average WTP per QALY obtained under certainty were generally insensitive to scale. Budget constraints did not appear to bias results in either study. Hence, the observed differences signal an important and striking effect of introducing uncertainty (and probability weighting corrections) in eliciting WTP for health improvements, both in the size of estimates, and their validity. The estimates obtained by Bobinac et al. [11] can be compared with the existing estimates in the empirical literature, which are almost exclusively estimated under certainty. These range roughly between €10,000 and €45,000 [9, 10, 12] , aligning well with the lower and upper bound estimates for the full sample obtained in the previous study by Bobinac et al. [11] . Interestingly, while this study used Dutch data, other studies were conducted in various other countries (e.g. Denmark, UK, Australia, Taiwan and others), signalling perhaps a common lining.
Discussion
CUA is becoming an important source of information for decision-makers in the healthcare sector. To assess whether an intervention can be considered welfare improving, the results of CUA need to be judged against some appropriately set threshold, which, here, is taken to represent the monetary value of a QALY. However, valid estimates of this monetary value of a QALY are largely lacking. This study aimed at deriving valid and practically useful estimates of the monetary value of a QALY. It can be argued that only estimates that satisfy basic criteria of validity can be considered useful in the debate about the appropriate level of the CUA threshold.
We estimated the individual ex ante WTP per QALY under risk, using a large representative sample of the Dutch population and applying different specifications of the probability weighting function. Unweighted, the value of a QALY was estimated at €250,000. We investigated how different function specifications affect the estimates and their validity. As would be predicted by prospect theory, the WTP per QALY estimates corrected for probability weighting have better validity and are more practically meaningful than the non-weighted estimates. These WTP per QALY estimates, ranging from €80,000 to €110,000 per QALY, may further inform policy-makers regarding the monetary value of health gains. Indeed, they compare well to the figures reported by the Council for Public Health and Care (RVZ) in the Netherlands [44] . However, more general comparisons between the results of the current study and other (international) studies are hampered by methodological differences. In this context, the most significant difference is the predominant absence of uncertainty in estimating the value of a QALY. Interestingly, our values compare well to the UK values reported by Mason et al. [45] , estimated under uncertainty. Although this study applied a different approach than the one presented here (modelling the value of a QALY from the value of a statistical life using UK data), it inferred the WTP for a QALY to range up to €80,000 in 2013 prices.
Our results showed higher sensitivity after probability weighting correction, supporting the idea that non-linear weighting is empirically important in explaining choice behaviour [46] and important in deriving WTP estimates obtained under uncertainty. Assuming that the weighted results are theoretically more correct, one can argue that the failure to account for probability weighting resulted in an overestimation of WTP per QALY (with a factor 2-3 in this study). Moreover, it resulted in less favourable conclusions regarding the validity of our estimates. Given the concerns about the validity of existing WTP per QALY estimates [5] , our findings may be considered encouraging. Many previous studies showed less favourable results in terms of validity [35, 47, 48] . Nevertheless, confirmation of our findings in future empirical studies and in different settings is pivotal and we still need to be cautious in interpreting our findings, as discussed below. These results highlight a number of important issues and areas for further research. First, in comparison with the results of a similar study valuing health gains under certainty [8, 11] , we find significant differences-in terms of both the size of WTP estimates and their validity. In terms of size, the higher WTP per QALY estimates reported here appear to result from the fact that, while 'raw' WTP responses were comparable between studies, the uncertainty introduced here decreased the size of the expected QALY gain in the denominator. In terms of sensitivity, higher sensitivity to scale observed here may be due to the reduced number of the WTP questions presented to respondents and to the fact that the two questions related to a single scenario, differing only in the risk of the health decrement. The lower cognitive burden may thus have made it easier for respondents to exhibit a higher level of sensitivity. Alternatively, it could be argued that it was easy for respondents to fixate on the halving of the probability between Q1 and Q2. However, we note that simply halving the stated WTP by participants in response to halving the probability of health loss would have resulted in more sensitivity in the non-weighted estimates than in those corrected for probability weighting. The contrary was observed in this study. In addition, only varying the size of the health gain also resulted in significantly different WTP responses. This implies that there is more sensitivity in the estimates than only invoked by adjusting the WTP to halving of probabilities. In that sense, the sensitivity observed here is encouraging and suggests that WTP elicited under uncertainty may in fact lead to more valid answers than when estimates are obtained under uncertainty, possibly because it increases the realism of the contingent market.
Second, we found clear heterogeneity in WTP responses. As expected, WTP increases with income and decreases with health status. Whether and how such heterogeneity should be reflected in healthcare decisionmaking is an issue that goes beyond the scope of this paper, but clearly relates to notions of equity that are central in the healthcare sector [49] . Moreover, it has been argued that the estimates from more certain respondents are a closer representation of the real WTP (as opposed to a hypothetical WTP [42] ). In this study, more certain respondents provided a lower average WTP per QALY, ranging between €64,000 (P function) and €87,000 (TK function). However, higher levels of sensitivity were not observed among more certain respondents, unlike as reported in previous studies [50] . From the perspective of social decision-making, using only a selection of responses may decrease the representativeness of the results and may thus be considered undesirable.
Third, applying different probability weighting functions resulted in different WTP per QALY estimates. In our study, the TK and GW functions produced similar results. Their use improved scale sensitivity, yielding a 'nearproportional' relationship between the size of the health gain and the elicited WTP. The P function performed less well than the other two weighting functions in this respect and produced a-less plausible-modestly convex relationship between size of the health gain and WTP. Therefore, while correcting for probability weighting appears advisable, more research is warranted into the appropriate weighting functions to be applied in this context. Similarly, one may be concerned with the application of probability weights more generally and wonder if the appropriate magnitude of the weights (or the appropriate weighting function) is, in fact, person-specific. The same concern regards the parameter estimates applied within the weighting functions (although these seem to be used regularly as average estimates). The debate about the appropriateness-or the consequence-of applying an average weight or a weighting function to all responses is beyond the scope of this study and certainly beyond its testing capabilities as no counterfactual data exist. However, future studies focusing on estimating the monetary values under uncertainty could estimate the person-specific weights alongside and hence more adequately address this potentially very relevant issue.
Study Limitations
A number of limitations of this study need to be mentioned. First, our sample was representative of the 18-to 65-yearold Dutch population in terms of age, gender and education, but not in terms of health status or other relevant socio-demographics. This might impede generalizability of our results. Note that respondents were asked to imagine being in the better of the two health states presented in a scenario, which should have rendered own health irrelevant. In other words, the position of the initial and potential health state presented in the scenarios should not have been influenced by own health, and whether these health states constituted a gain or a loss, relative to own health. However, our data did not allow a firm test of this assumption. Similarly, the levels of risk presented here were meant to be strictly exogenous. The ability to self-protect against health deterioration (a component of realized risk faced by the individual [51, 52] ) should therefore be irrelevant for WTP estimates. If the probabilities used by respondents were, nonetheless, partly endogenous, it would be inappropriate to treat them as exogenous in econometric models [53] , and future research might explore models estimating WTP per QALY that include perceived (subjective) risks [54, 55] . Second, design-specific choices, such as the range of the PS and the choice of the payment vehicle, may have affected our results by fostering biases (e.g. an anchor bias stemming from the range of the PS). We elicited WTP using direct out-of-pocket payments as payment vehicle, rather than insurance premiums or taxes. Although Dutch citizens are somewhat acquainted with paying out of pocket for healthcare (8 % of healthcare in the Netherlands is financed out of pocket [56] , and increasingly so since the introduction of a mandatory deductible [57] ), the extent to which out-of-pocket payments seemed realistic to respondents is unclear. Moreover, the finding of relatively good sensitivity to scale when lowering the probability of health deterioration may not have been observed had we increased (e.g. doubled) the probability of health deterioration rather than decreased it moving from Q1 to Q2. People may more easily lower subsequent WTP answers than increase subsequent WTP answers (proportional to the gain on offer). Unfortunately, we could not test this further here. Similarly, we asked respondents to value avoidance of potential health losses. Framing similar questions as health gains could yield different, presumably lower, WTP per QALY estimates, due to health-related loss aversion (i.e. respondents being more sensitive to potential losses than potential gains). Moreover, respondents only valued potential QOL improvements, not potential mortality reductions. While many healthcare interventions indeed aim to improve QOL rather than to reduce mortality, obtaining estimates in the context of mortality reductions remains important. More research into developing methods to do so (while avoiding obvious problems, e.g. diminished marginal utility of income due to imminent death) seems required, also given important policy questions regarding so-called end-of-life treatments. Finally, our design combined lower probabilities with larger health gains, and vice versa. This resulted in less variation in the size of the gains presented in the exercises. One might argue that if WTP were fully insensitive to the size of QALY gains, our design might still have yielded relatively favourable results and fairly constant WTP per QALY estimates, therefore. However, we stress that there was clear variation in expected QALY gain size. Moreover, the (variation in) gains were larger when correcting for probability weighting, and we observed better sensitivity after correction. This emphasizes that our findings are not a mere artefact of design. However, confirming these findings using different designs is advocated.
Conclusions
This study has derived estimates of the monetary value of a QALY under uncertainty and demonstrated the importance of correcting for probability weighting in using responses. Given the reasonable support for their validity and practical meaningfulness, the estimates derived while correcting for probability weighting may provide valuable input for the debate on the consumption value of health. While decision makers should not apply these estimates without further consideration, since strictly individual valuations may not carry all relevant information and values for societal decision-making [58] , the current estimates may provide a good and informed basis for further discussion and study of this important topic.
